We discovered that the exogenous supplementation of rehLTF can suppress calcification, senescence, and ECM degradation in CEPs via the JAK2/STAT3 signalling pathway, thereby alleviating CEP degeneration and delaying IDD progress. The gene discussed is STAT3; the disease is intervertebral disk degenerative disorder.